LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings.

Midha, Ish K / Kumar, Nilesh / Kumar, Amit / Madan, Taruna

Reviews in medical virology

2020  Volume 31, Issue 5, Page(s) 1–14

Abstract: Of all the nutrients, vitamin A has been the most extensively evaluated for its impact on immunity. There are three main forms of vitamin A, retinol, retinal and retinoic acid (RA) with the latter being most biologically active and all-trans-RA (ATRA) ... ...

Abstract Of all the nutrients, vitamin A has been the most extensively evaluated for its impact on immunity. There are three main forms of vitamin A, retinol, retinal and retinoic acid (RA) with the latter being most biologically active and all-trans-RA (ATRA) its main derivative. Vitamin A is a key regulator of the functions of various innate and adaptive immune cells and promotes immune-homeostasis. Importantly, it augments the interferon-based innate immune response to RNA viruses decreasing RNA virus replication. Several clinical trials report decreased mortality in measles and Ebola with vitamin A supplementation.During the Covid-19 pandemic interventions such as convalescent plasma, antivirals, monoclonal antibodies and immunomodulator drugs have been tried but most of them are difficult to implement in resource-limited settings. The current review explores the possibility of mega dose vitamin A as an affordable adjunct therapy for Covid-19 illness with minimal reversible side effects. Insight is provided into the effect of vitamin A on ACE-2 expression in the respiratory tract and its association with the prognosis of Covid-19 patients. Vitamin A supplementation may aid the generation of protective immune response to Covid-19 vaccines. An overview of the dosage and safety profile of vitamin A is presented along with recommended doses for prophylactic/therapeutic use in randomised controlled trials in Covid-19 patients.
MeSH term(s) Animals ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19/virology ; Humans ; Immunity/drug effects ; Immunomodulation/drug effects ; SARS-CoV-2/genetics ; SARS-CoV-2/physiology ; Vitamin A/administration & dosage ; Vitamin A/analysis
Chemical Substances Vitamin A (11103-57-4)
Language English
Publishing date 2020-12-31
Publishing country England
Document type Journal Article ; Review
ZDB-ID 1086043-5
ISSN 1099-1654 ; 1052-9276
ISSN (online) 1099-1654
ISSN 1052-9276
DOI 10.1002/rmv.2204
Shelf mark
Zs.A 3308: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top